Blocking IL-1, IL-33 and IL-36 Signaling with the Anti-IL1RAP Antibody mCAN10 Ameliorates Inflammation and Fibrosis in Preclinical Models of Systemic Sclerosis-MedSci.cn

Blocking IL-1, IL-33 and IL-36 Signaling with the Anti-IL1RAP Antibody mCAN10 Ameliorates Inflammation and Fibrosis in Preclinical Models of Systemic Sclerosis

Gronberg, C; Rattik, S; Kunz, M; Thoung, TM; Cuong, TM; Zhou, X; Skoog, P; Liberg, D; Distler, J

ARTHRITIS & RHEUMATOLOGY, 2022; 74 (): 3227

科室
- - 订阅+
  - 更多科室
工具
服务